Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients

Toxicology Letters

Volumn 150, Issue 2, 2004, Pages 211-219

  Wu, Ming Fang ^a,b   Wu, Wen Jun ^b   Chang, Gee Chen ^b,c   Chen, Chin Yi ^c   Hu, Suh Woan ^b   Tsai, Wen Tin ^b   Lee, Huei ^b   Lin, Pinpin ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Aryl hydrocarbon receptor; Cytochrome P4501A1; Cytochrome P4501B1; Lung cancer

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; LEUCINE; MESSENGER RNA; VALINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

AGE FACTORS; ARYL HYDROCARBON HYDROXYLASES; CARCINOMA; CYTOCHROME P-450 CYP1A1; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS;

EID: 1842839901     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.01.006     Document Type: Article

References (41)

1. Aklillu E., Oscarson M., Hidestrand M., Leidvik B., Otter C., Ingelman-Sundberg M. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population. Mol. Pharmacol. 61:2002;586-594.
2. Boffetta P., Jourenkova N., Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Contr. 8:1997;444-472.
3. Cavalieri E., Frenkel K., Liehr J.G., Rogan E., Roy D. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 27:2000;75-93.
4. Chang C.Y., Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol. Cell Biol. 18:1998;525-535.
5. Chang K.W., Lee H., Wang H.J., Chen S.Y., Lin P. Differential response to benzo[A]pyrene in human lung adenocarcinoma cell lines: the absence of aryl hydrocarbon receptor activation. Life Sci. 65:1999;1339-1349.
6. Convert O., Van Aerden C., Debrauwer L., Rathahao E., Molines H., Fournier F., Tabet J.C., Paris A. Reactions of estradiol-2,3-quinone with deoxyribonucleosides: possible insights in the reactivity of estrogen quinones with DNA. Chem. Res. Toxicol. 15:2002;754-764.
7. Crawford R.B., Holsapple M.P., Kaminski N.E. Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand. Mol. Pharmacol. 52:1997;921-927.
8. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43:2003;309-334.
9. Dertinger S.D., Nazarenko D.A., Silverstone A.E., Gasiewicz T.A. Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis. 22:2001;171-177.
10. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140:1996;173-179.
11. Hatanaka N., Yamazaki H., Oda Y., Guengerich F.P., Nakajima M., Yokoi T. Metabolic activation of carcinogenic 1-nitropyrene by human cytochrome P450 1B1 in Salmonella typhimurium strain expressing an O-acetyltransferase in SOS/umu assay. Mutat. Res. 497:2001;223-233.
12. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91:1999;1194-1210.
13. Inoue K., Asao T., Shimada T. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. Xenobiotica. 30:2000;285-295.
14. Jacquet M., Lambert V., Todaro A., Kremers P. Mitogen-activated lymphocytes: a good model for characterising lung CYP1A1 inducibility. Eur. J. Epidemiol. 13:1997;177-183.
15. Kellermann G., Shaw C.R., Luyten-Kellerman M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 289:1973;934-937.
16. Kiyohara C., Nakanishi Y., Inutsuka S., Takayama K., Hara N., Motohiro A., Tanaka K., Kono S., Hirohata T. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics. 8:1998;315-323.
17. Kogevinas M. Studies of cancer in humans. Food Addit. Contam. 17:2000;317-324.
18. Kress S., Greenlee W.F. Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57:1997;1264-1269.
19. Liehr J.G., Fang W.F., Sirbasku D.A., Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24:1986;353-356.
20. Lin P., Chang H., Ho W.L., Wu M.-H., Su J.-M. Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers. Lung Cancer. 42:2003a;255-261.
21. Lin P., Hu S.W., Chang T.H. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol. Sci. 71:2003;20-26.
22. Ma Q., Whitlock J.P. Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol. Cell Biol. 16:1996;2144-2150.
23. Mollerup S., Ryberg D., Hewer A., Phillips D.H., Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 59:1999;3317-3320.
24. Moon R.C., Rao K.V., Detrisac C.J. Respiratory carcinogenesis of nitroaromatics. Res. Rep. Health Eff. Inst. 32:1990;1-29.
25. Murray G.I., Taylor M.C., McFadyen M.C., McKay J.A., Greenlee W.F., Burke M.D., Melvin W.T. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 57:1997;3026-3031.
26. Nebert D.W. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20:1989;153-174.
27. Prasad R., Prasad N., Harrell J.E., Thornby J., Liem J.H., Hudgins P.T., Tsuang J. Aryl hydrocarbon hydroxylase inducibility and lymphoblast formation in lung cancer patients. Int. J. Cancer. 23:1979;316-320.
28. Prescott E., Osler M., Hein H.O., Borch-Johnsen K., Lange P., Schnohr P., Vestbo J. Gender and smoking-related risk of lung cancer. the Copenhagen center for prospective population studies. Epidemiology. 9:1998;79-83.
29. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56:1996;2979-2984.
30. Shimada T., Watanabe J., Inoue K., Guengerich F.P., Gillam E.M. Specificity of 17beta-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432. Xenobiotica. 31:2001;163-176.
31. Shimada T., Watanabe J., Kawajiri K., Sutter T.R., Guengerich F.P., Gillam E.M., Inoue K. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis. 20:1999;1607-1613.
32. Shimada T., Yun C.H., Yamazaki H., Gautier J.C., Beaune P.H., Guengerich F.P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 41:1992;856-864.
33. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., Fujii-Kuriyama Y., Ishikawa T. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U.S.A. 97:2000;779-782.
34. Spencer D.L., Masten S.A., Lanier K.M., Yang X., Grassman J.A., Miller C.R., Sutter T.R., Lucier G.W., Walker N.J. Quantitative analysis of constitutive and 2378-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes. Cancer Epidemiol. Biomarkers Prev. 8:1999;139-146.
35. Spivack S.D., Hurteau G.J., Reilly A.A., Aldous K.M., Ding X., Kaminsky L.S. CYP1B1 expression in human lung. Drug Metab. Dispos. 29:2001;916-922.
36. Toide K., Yamazaki H., Nagashima R., Itoh K., Iwano S., Takahashi Y., Watanabe S., Kamataki T. Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins. Cancer Epidemiol. Biomarkers Prev. 12:2003;219-222.
37. Ward E., Paigen B., Steenland K., Vincent R., Minowada J., Gurtoo H.L., Sartori P., Havens M.B. Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer. Int. J. Cancer. 22:1978;384-389.
38. Watanabe J., Shimada T., Gillam E.M., Ikuta T., Suemasu K., Higashi Y., Gotoh O., Kawajiri K. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics. 10:2000;25-33.
39. Whitlock J.P. Jr. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:1999;103-125.
40. Yamazaki H., Hatanaka N., Kizu R., Hayakawa K., Shimada N., Guengerich F.P., Nakajima M., Yokoi T. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A1, and 1B1. Mutat. Res. 472:2000;129-138.
41. Zang E.A., Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. J. Natl. Cancer Inst. 88:1996;183-192.